Rinucumab (Anti-PDGFRB / CD140b)

Synonyms: REGN 2176

Catalog No.A2378 Purity:99%

Rinucumab (Anti-PDGFRB / CD140b) is an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta) monoclonal antibody and has a potential to study neovascular age-related macular degeneration. MW: 145.5 kD.

Purity & Quality Control

Batch: A237801 Purity: 99% Protein concentration: 5.74mg/ml Endotoxin Level: ＜1EU/mg

Choose Selective PDGFR Inhibitors

Name	Citation	PDGFR	PDGFRα	PDGFRβ	Others
Dovitinib (TKI-258)	49			+++	FLT3,c-Kit,VEGFR3/FLT4
Linifanib (ABT-869)	32			++	VEGFR1/FLT1,CSF-1R,VEGFR2/KDR
Crenolanib	93		++++	++++
Masitinib	40		+	+	Kit,Lyn B,Abl1
Amuvatinib (MP-470)	19		++		c-Kit (D816H),FLT3 (D835Y)
Motesanib Diphosphate (AMG-706)	12	++			VEGFR1,VEGFR2,VEGFR2/Flk1
Orantinib (SU6668)	20			+++
CP-673451	33		+++	++++
Ki8751	20		++		VEGFR2,c-Kit
Telatinib	5		+++		c-Kit,VEGFR3,VEGFR2
PP121	5	++++			Hck,VEGFR,mTOR
MK-2461	4			+++	c-Met (M1250T),c-Met (Y1235D),c-Met (Y1230H)
Tyrphostin AG 1296	14	+			c-Kit (Swiss 3T3),FGFR (Swiss 3T3)
Tyrphostin 9	1	+			EGFR
Dovitinib (TKI258) Lactate monohydrate	30			+++	FLT3,c-Kit,FGFR1
AZD2932	3			+++	Flt3,VEGFR-2,c-Kit
Sennoside B	✔

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description	Rinucumab (Anti-PDGFRB / CD140b) is an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta) monoclonal antibody and has a potential to study neovascular age-related macular degeneration. MW: 145.5 kD.

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1569263-06-4
Molecular Weight	145.5 kDa
Isotype	Human IgG4SP
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

* Name Please enter your name.

* Email Please enter your email. Please enter a valid email address.

Phone

* Comments: Please write something to us.

Tags: buy Rinucumab (Anti-PDGFRB / CD140b) | Rinucumab (Anti-PDGFRB / CD140b) supplier | purchase Rinucumab (Anti-PDGFRB / CD140b) | Rinucumab (Anti-PDGFRB / CD140b) cost | Rinucumab (Anti-PDGFRB / CD140b) manufacturer | order Rinucumab (Anti-PDGFRB / CD140b) | Rinucumab (Anti-PDGFRB / CD140b) distributor